WO2007026207A1 - Direct aminolysis - Google Patents
Direct aminolysis Download PDFInfo
- Publication number
- WO2007026207A1 WO2007026207A1 PCT/IB2006/002337 IB2006002337W WO2007026207A1 WO 2007026207 A1 WO2007026207 A1 WO 2007026207A1 IB 2006002337 W IB2006002337 W IB 2006002337W WO 2007026207 A1 WO2007026207 A1 WO 2007026207A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- reaction
- compound
- reagent
- vessel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
- C07C209/22—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of other functional groups
Definitions
- the present invention relates to preparing amines from corresponding mesylates or oximes, including convenient large scale reactions. Others have prepared amines from mesylates and other starting materials. However, there remains a need for improved methods.
- the present invention provides a method of preparing a compound of the formula:
- R 2 (I) comprising reacting by direct aminolysis a mesylate compound of the formula:
- R 2 (II) with a reagent comprising ammonia is preferably carried out in a solvent, such as an alcohol, and is preferably carried out in a sealed vessel such as a Parr reactor or the like.
- a sealed vessel such as a Parr reactor or the like.
- the sealed vessel advantageously prevents the escape of reagents and can provide relatively high reaction pressures.
- the invention can be successfully practiced at small or large scale, as desired.
- the structure of each of R 1 , R 2 , and A in a given synthesis is preferably carried through unchanged from the starting material Formula II.
- the definitions of R 1 , R 2 , and A are the same for all of the generic formulas disclosed herein.
- Each R 1 and R 2 can independently be, e.g., (C r C 6 )alky), (C 2 -C 6 )alkenyl, or (C 2 -C 6 )alkynyl, any of which can optionally be substituted by one or more 4 to 6 membered carbocyclic or heterocyclic groups.
- A is preferably (C r C 6 )alkylene, (C 2 -C 6 )alkenyl, or (C 2 -C 6 )alkynyl, and R 2 and A can, together with the nitrogen to which they are attached, form a 4 to 7 membered ring such as azetidinyl, pyrrolidinyl, or piperidinyl.
- R 1 , R 2 , and A can also be further substituted or can be interrupted by, e.g., oxygen, nitrogen, or sulfur.
- substituents e.g., oxygen, nitrogen, or sulfur.
- the nature of these substituents is not limiting of the invention. Rather, the aminolysis described herein is generally applicable.
- the present invention includes methods of direct aminolysis of mesylates (methane sulfonates) to obtain corresponding amines.
- the present invention provides a method of preparing a compound of the formula:
- each R 1 and R 2 is independently (C r C 6 )alkyl, any of which is optionally substituted by one or more (e.g., 1 to 4) 4 to 6 membered carbocyclic or heterocyclic groups;
- A is (C r C 6 )alkylene; and R 2 and A can, together with the nitrogen to which they are attached, form a 4 to 7 membered ring; comprising reacting a compound of the formula:
- R 2 and A together with the nitrogen to which they are attached, form an azetidinyl ring.
- R 1 is benzhydryl. In some embodiments, R 1 is benzhydryl, and R 2 and A, together with the nitrogen to which they are attached, form an azetidinyl ring.
- the reaction is carried out in a solvent comprising an alcohol, which can comprise isopropyl alcohol and/or methanol.
- the reagent is added to the vessel as comprising aqueous ammonium hydroxide.
- the reagent is added to the vessel as ammonia in an alcohol carrier, such as methanol.
- an alcohol carrier such as methanol.
- 28% aqueous ammonium hydroxide can be used in a reaction with isopropanol as the solvent (e.g., 1 volume ammonium hydroxide to 1.5 volumes alcohol), or 7N ammonia in methanol can be used.
- the yield of Formula I is at least about 70% on a molar basis, or at least about 80% on a molar basis. Moreover, such yields can be obtained at scales affording at least about 500 g or at least about 1000 g of Formula I.
- the side product Formula I dimer can appear in a ratio to Formula I of about 6:94 or less, or about 4% or less of the resulting products.
- the reaction is heated to at least about 50°, 60°, or at least about 7O 0 C. In some embodiments, the reaction pressure reaches at least about 20, 25, 30, 35, or 40 psi.
- reaction in the vessel is brought to at least about 5O 0 C and at least about 25 psi.
- the reaction product is isolated by any suitable combination of evaporation, extraction, or recrystallization (e.g., with or from isopropyl ether).
- R 1 , R 2 , and A in Formula III are as defined for Formula II.
- the present invention also provides all of the steps of preparing compounds of Formula I by Swern oxidation of Formula III (e.g., oxalyl chloride, DMSO, -78 0 C), condensation (e.g., hydroxylamine hydrochloride), reduction (e.g., LiAIH 4 ), and isolation (e.g., oxalic acid salt).
- Swern oxidation of Formula III e.g., oxalyl chloride, DMSO, -78 0 C
- condensation e.g., hydroxylamine hydrochloride
- reduction e.g., LiAIH 4
- isolation e.g., oxalic acid salt
- the mesylate wet cake (838 g dry weight expected, 2.64 mol) (Example 1) was dissolved in isopropanol at 50°C.
- the solution was charged to a 2 gallon Parr reactor, followed by the addition of 28 wt% ammonium hydroxide under vacuum (10 vol of 28% NH 4 OH and 15 vol of isopropanol).
- the Parr reactor was sealed, and heated to 71 °C for 3 h (38 - 40 psi pressure observed).
- the reaction was assayed by HPLC, and showed reaction completion.
- the reaction mixture was cooled to room temperature, discharged from the Parr reactor, and concentrated under vacuum.
- the product was extracted with isopropyl ether (8.4 L).
- the reaction conditions were similar to Example 2, except that 10 volumes 7N ammonia in methanol was added under vacuum to 15 volumes isopropanol. The reaction was heated to 70-75 0 C resulting in a pressure of 40-50 psi. After three hours, the reaction was nearly complete with a ratio of IV to its dimer of 94:6 by HPLC. The product was isolated by evaporation and recrystallized from isopropyl ether to give a 70% yield.
- a or “an” mean at least one.
- a compound X means at least compound X and can include other compounds or materials.
- composition comprising
- “comprising” is open, even where materials are recited in the alternative.
- “comprising a compound X or Y” means at least compound X or compound Y but can include both compounds X and Y and/or additional compounds and/or components.
- alkyl as used herein, unless otherwise indicated, means a saturated monovalent hydrocarbon radical including cyclic (“cycloalkyl”), straight and/or branched structure.
- alkenyl as used herein, unless otherwise indicated, means straight-chain, cyclic, or branched-chain hydrocarbon radicals containing at least one carbon-carbon double bond.
- alkenyl radicals include ethenyl, E- and Z-propenyl, isopropenyl, E- and Z-butenyl, E- and Z-isobutenyl, E- and Z-pentenyl, E- and Z-hexenyl, E 1 E-, E 1 Z-, Z 1 E-, Z,Z-hexadienyl, and the like.
- alkynyl as used herein, unless otherwise indicated, means straight-chain or branched- chain hydrocarbon radicals containing at least one carbon-carbon triple bond.
- alkynyl radicals include ethynyl, E- and Z-propynyl, isopropynyl, E- and Z-butynyl, E- and Z-isobutynyl, E- and Z-pentynyl, E, Z-hexynyl, and the like.
- aryl as used herein, unless otherwise indicated, means a fully aromatic radical containing only carbon atoms in its ring system. Non-limiting examples include phenyl, napthyl, and anthracenyl.
- carbocyclic as use herein, unless otherwise indicated, means a ring system containing only carbon atoms in the ring system without regard to aromaticity.
- a carbocyclic moiety can be aryl or non- aryl, wherein non-aryl includes saturated and unsaturated rings, and ring systems having aromatic and/or non-aromatic portions. Examples of carbocyclics include phenyl, naphthyl, cyclohexenyl, and indenyl.
- 4-6 membered carbocyclic means monocyclic carbocyclic ring systems having 4 to 6 ring carbons.
- heteroaryl means a fully aromatic radical containing at least one heteroatom in its ring system.
- 5-6 membered heteroaryl include, thiophenyl, isoxazolyl, 1 ,2,3-triazolyl, 1 ,2,3-oxadiazolyl, 1 ,2,3-thiadiazolyl, 1 ,2,4-triazolyl, 1 ,3,4-oxadiazolyl, 1 ,3,4-thiadiazolyl, 1 ,2,5-oxadiazolyl, 1 ,2,5-thiadiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1 ,2,4 oxadiazolyl, 1 ,2,5-triazinyl, 1 ,3,5-triazinyl, and the like.
- Heteroaryls include, e.g., 5 and 6 membered monocyclics such as pyrrolyl and pyridinyl.
- Other examples of heteroaryl include pyridinyl, imidazolyl, pyrimidinyl, pyrazolyl, triazolyl, pyrazinyl, tetrazolyl, furanyl, thienyl, isoxazolyl, thiazolyl, oxazolyl, isothiazolyl, pyrrolyl, quinolinyl, isoquinolinyl, indolyl, benzimidazolyl, benzofuranyl, cinnoiinyl, indazolyl, indolizinyl, phthalazinyl, pyridazinyl, triazinyl, isoindolyl, pteridinyl, purinyl, oxadiazolyl, thiadiazolyl, furazany
- heterocyclic means any ring system containing at least one of N, O, or S, and can be heteroaryl or otherwise.
- Non-aryl heterocyclic groups include saturated and unsaturated systems and can include groups having only 4 atoms in their ring system.
- the heterocyclic groups include benzo-fused ring systems and ring systems substituted with one or more oxo moieties.
- Ring sulfur can be in the form of sulfoxide or sulfone where feasible. Included are 4-6 membered ring systems ("4-6 membered heterocyclic”), which include 5-6 membered heteroaryls, and include groups such as azetidinyl and piperidinyl.
- Heterocyclics can be heteroatom-attached where such is possible. For instance, a group derived from pyrrole can be pyrrol-1-yl (N-attached) or pyrrol-3-yl (C- attached).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/065,247 US20080242874A1 (en) | 2005-08-31 | 2006-08-21 | Direct Aminolysis |
EP06795347A EP1924549A1 (en) | 2005-08-31 | 2006-08-21 | Direct aminolysis |
BRPI0615113-2A BRPI0615113A2 (en) | 2005-08-31 | 2006-08-21 | direct aminolysis |
CA002616539A CA2616539A1 (en) | 2005-08-31 | 2006-08-21 | Direct aminolysis |
AU2006286277A AU2006286277A1 (en) | 2005-08-31 | 2006-08-21 | Direct aminolysis |
IL189130A IL189130A0 (en) | 2005-08-31 | 2008-01-30 | Direct aminolysis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71326605P | 2005-08-31 | 2005-08-31 | |
US60/713,266 | 2005-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007026207A1 true WO2007026207A1 (en) | 2007-03-08 |
Family
ID=37507655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/002337 WO2007026207A1 (en) | 2005-08-31 | 2006-08-21 | Direct aminolysis |
Country Status (14)
Country | Link |
---|---|
US (1) | US20080242874A1 (en) |
EP (1) | EP1924549A1 (en) |
JP (1) | JP2007063279A (en) |
KR (1) | KR20080031489A (en) |
CN (1) | CN101253143A (en) |
AR (1) | AR057781A1 (en) |
AU (1) | AU2006286277A1 (en) |
BR (1) | BRPI0615113A2 (en) |
CA (1) | CA2616539A1 (en) |
IL (1) | IL189130A0 (en) |
RU (1) | RU2008107720A (en) |
TW (1) | TW200722407A (en) |
WO (1) | WO2007026207A1 (en) |
ZA (1) | ZA200801047B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5977381A (en) * | 1998-01-12 | 1999-11-02 | Hoffmann-La Roche Inc. | Process for making 3-amino-pyrolidine derivatives |
US20040157823A1 (en) * | 2000-03-03 | 2004-08-12 | Aventis Pharma S.A. | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
-
2006
- 2006-08-21 RU RU2008107720/04A patent/RU2008107720A/en not_active Application Discontinuation
- 2006-08-21 BR BRPI0615113-2A patent/BRPI0615113A2/en not_active IP Right Cessation
- 2006-08-21 AU AU2006286277A patent/AU2006286277A1/en not_active Abandoned
- 2006-08-21 CN CNA200680031357XA patent/CN101253143A/en active Pending
- 2006-08-21 US US12/065,247 patent/US20080242874A1/en not_active Abandoned
- 2006-08-21 WO PCT/IB2006/002337 patent/WO2007026207A1/en active Application Filing
- 2006-08-21 KR KR1020087004939A patent/KR20080031489A/en not_active Application Discontinuation
- 2006-08-21 EP EP06795347A patent/EP1924549A1/en not_active Withdrawn
- 2006-08-21 CA CA002616539A patent/CA2616539A1/en not_active Abandoned
- 2006-08-29 AR ARP060103756A patent/AR057781A1/en unknown
- 2006-08-30 TW TW095132047A patent/TW200722407A/en unknown
- 2006-08-30 JP JP2006233613A patent/JP2007063279A/en active Pending
-
2008
- 2008-01-30 IL IL189130A patent/IL189130A0/en unknown
- 2008-01-31 ZA ZA200801047A patent/ZA200801047B/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5977381A (en) * | 1998-01-12 | 1999-11-02 | Hoffmann-La Roche Inc. | Process for making 3-amino-pyrolidine derivatives |
US20040157823A1 (en) * | 2000-03-03 | 2004-08-12 | Aventis Pharma S.A. | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
Non-Patent Citations (2)
Title |
---|
BARCACHYN ET. AL.: "Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens", JOURNAL OF MEDICINAL CHEMISTRY, vol. 46, 2003, pages 284 - 302, XP002412110 * |
FRIGOLA J ET AL: "7-Azetidinylquinolones as Antibacterial Agents. 3. Synthesis, Properties and Structure-Activity Relationships of the Stereoisomers Containing a 7-(3-Amino-2-methyl-1-azetidinyl) Moiety", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 38, no. 7, 1995, pages 1203 - 1215, XP002115345, ISSN: 0022-2623 * |
Also Published As
Publication number | Publication date |
---|---|
IL189130A0 (en) | 2008-08-07 |
EP1924549A1 (en) | 2008-05-28 |
CA2616539A1 (en) | 2007-03-08 |
KR20080031489A (en) | 2008-04-08 |
JP2007063279A (en) | 2007-03-15 |
AU2006286277A1 (en) | 2007-03-08 |
AR057781A1 (en) | 2007-12-19 |
US20080242874A1 (en) | 2008-10-02 |
CN101253143A (en) | 2008-08-27 |
TW200722407A (en) | 2007-06-16 |
RU2008107720A (en) | 2009-09-10 |
BRPI0615113A2 (en) | 2011-05-03 |
ZA200801047B (en) | 2008-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110590635A (en) | Preparation method of levetiracetam and intermediate thereof | |
KR19990013522A (en) | Process for preparing substituted perhydroisoindole | |
JP2004520446A (en) | Crystallization method of losartan potassium | |
CN106699595A (en) | Preparation method for lacosamide | |
WO2007026207A1 (en) | Direct aminolysis | |
CN113227075A (en) | Novel process for the production of N, N' -bis [2- (1H-imidazol-4-yl) ethyl ] malonamide | |
US6897299B2 (en) | Process for producing erythromycin derivative | |
CN108976140B (en) | Preparation method and intermediate of 2-amino-6-ethylbenzoic acid | |
KR870001569B1 (en) | Preparing process for pyrolidine derivatives | |
CN112608247B (en) | Preparation method of capsaicin and capsaicin prepared by using same | |
JP2714396B2 (en) | Preparation of pyrrolidine derivatives | |
CA2436265A1 (en) | 3-(3-amidinophenyl)-5-[({[1-(1-iminoethyl)-4-piperidyl]methyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same | |
CN115504886B (en) | Preparation method of halogenated phenethylamine compound | |
KR101974388B1 (en) | Alkyl diethylene triamine derivatives and a process of the preparation thereof | |
JP2682713B2 (en) | Production of optically active tetrahydrofuran | |
SU545259A3 (en) | The method of obtaining-substituted cycloserine compounds or their salts | |
WO2008035189A1 (en) | A method for the purification of lansoprazole | |
JPH072742A (en) | New production method of 4-amino-3-methyl-n-ethyl-n-(beta-hydroxyethyl)aniline sulfuric acid salt | |
JP2006056832A (en) | Method for producing and purifying 4-hydroxyquinolines | |
US20230348391A1 (en) | An improved process for the preparation of trigonelline or pharmaceutically acceptable salts thereof | |
CN111253288A (en) | Synthesis method of N, N' -diisopropyl-O- (4-nitrobenzyl) isourea | |
JP2005521688A (en) | Method for producing 2-anilino-4,6-dimethylpyrimidine | |
KR820001121B1 (en) | Process for preparing 2-amino-methyl pyrolidine | |
SU509223A3 (en) | The method of obtaining derivatives of 1-carbamoylimidazole | |
KR100297802B1 (en) | Method for preparing 2- (3-trifluoromethyl) anilinonicotinic acid 2- (N-morpholine) ethyl. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2616539 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 189130 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 565832 Country of ref document: NZ Ref document number: 1160/DELNP/2008 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006286277 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200680031357.X Country of ref document: CN Ref document number: 2006795347 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2008/002859 Country of ref document: MX Ref document number: 2008107720 Country of ref document: RU Ref document number: 12065247 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2006286277 Country of ref document: AU Date of ref document: 20060821 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006286277 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006795347 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0615113 Country of ref document: BR Kind code of ref document: A2 Effective date: 20080227 |